Benefit-Risk Assessment of Off-Label Drug Use in Children: The Bravo Framework.
van der Zanden TM, Mooij MG, Vet NJ, Neubert A, Rascher W, Lagler FB, Male C, Grytli H, Halvorsen T, de Hoog M, de Wildt SN.
van der Zanden TM, et al.
Clin Pharmacol Ther. 2021 Oct;110(4):952-965. doi: 10.1002/cpt.2336. Epub 2021 Jul 29.
Clin Pharmacol Ther. 2021.
PMID: 34145575
Free PMC article.